Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-II)
Condition: Acute Ischemic Stroke Interventions: Drug: Alteplase; Drug: Tenecteplase Sponsors: Beijing Tiantan Hospital; Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd; The Place Pharmaceutical(Jiangsu) Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2022 Category: Research Source Type: clinical trials